US Stock MarketDetailed Quotes

ACBM ACRO BIOMEDICAL CO LTD

Watchlist
  • 0.105
  • 0.0000.00%
15min DelayClose Nov 15 16:00 ET
6.30MMarket Cap-420P/E (TTM)

ACRO BIOMEDICAL CO LTD Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
0
0
-45.01%658.5K
-39.80%360K
0
0
200.00%298.5K
74.06%1.2M
598K
0
Operating revenue
--0
--0
-45.01%658.5K
-39.80%360K
--0
--0
200.00%298.5K
74.06%1.2M
--598K
--0
Cost of revenue
0
0
-44.78%518K
-33.93%296K
0
0
217.14%222K
77.46%938K
448K
0
Gross profit
0
0
-45.86%140.5K
-57.33%64K
0
0
159.32%76.5K
62.79%259.5K
150K
0
Operating expense
-20.06%3.19M
-0.04%4M
101.31%16.01M
-0.12%4M
34.11%4.01M
357.61%4M
4,530.64%4.01M
2,643.70%7.95M
5,050.84%4M
4,080.34%2.99M
Selling and administrative expenses
-10.84%1.32M
-0.10%1.48M
122.28%5.93M
-0.32%1.48M
71.91%1.49M
537.51%1.48M
1,617.04%1.49M
820.39%2.67M
1,807.93%1.48M
1,112.18%867.21K
Research and development costs
-25.47%1.88M
0.00%2.52M
90.72%10.08M
0.00%2.52M
18.67%2.52M
292.69%2.52M
--2.52M
--5.29M
--2.52M
--2.12M
Operating profit
20.06%-3.19M
-1.91%-4M
-106.27%-15.87M
-2.11%-3.93M
-34.11%-4.01M
-403.76%-4M
-6,793.35%-3.93M
-5,797.13%-7.69M
-4,857.80%-3.85M
-4,080.34%-2.99M
Net non-operating interest income expense
-273.93%-789
-277.03%-788
59.86%-1.71K
-289.60%-787
-180.34%-499
84.56%-211
91.65%-209
16.37%-4.25K
90.63%-202
88.58%-178
Non-operating interest expense
273.93%789
277.03%788
-59.86%1.71K
289.60%787
180.34%499
-84.56%211
-91.65%209
-16.37%4.25K
-90.63%202
-88.58%178
Other net income (expense)
Income before tax
20.05%-3.2M
-1.92%-4M
-106.18%-15.87M
-2.12%-3.93M
-34.12%-4.01M
-402.92%-4M
-6,503.69%-3.93M
-5,579.17%-7.7M
-4,724.28%-3.85M
-3,991.48%-2.99M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
20.05%-3.2M
-1.92%-4M
-106.18%-15.87M
-2.12%-3.93M
-34.12%-4.01M
-402.92%-4M
-6,503.69%-3.93M
-6,453.96%-7.7M
-6,137.25%-3.85M
-3,991.48%-2.99M
Net income continuous Operations
20.05%-3.2M
-1.92%-4M
-106.18%-15.87M
-2.12%-3.93M
-34.12%-4.01M
-402.92%-4M
-6,503.69%-3.93M
-6,453.96%-7.7M
-6,137.25%-3.85M
-3,991.48%-2.99M
Minority interest income
Net income attributable to the parent company
20.05%-3.2M
-1.92%-4M
-106.18%-15.87M
-2.12%-3.93M
-34.12%-4.01M
-402.92%-4M
-6,503.69%-3.93M
-6,453.96%-7.7M
-6,137.25%-3.85M
-3,991.48%-2.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.05%-3.2M
-1.92%-4M
-106.18%-15.87M
-2.12%-3.93M
-34.12%-4.01M
-402.92%-4M
-6,503.69%-3.93M
-6,453.96%-7.7M
-6,137.25%-3.85M
-3,991.48%-2.99M
Basic earnings per share
28.57%-0.05
0.00%-0.07
-85.71%-0.26
14.29%-0.06
-40.00%-0.07
-250.00%-0.07
-5,517.98%-0.07
-5,593.37%-0.14
-5,313.77%-0.07
-3,165.84%-0.05
Diluted earnings per share
28.57%-0.05
0.00%-0.07
-85.71%-0.26
14.29%-0.06
-40.00%-0.07
-250.00%-0.07
-5,517.98%-0.07
-5,593.37%-0.14
-5,313.77%-0.07
-3,165.84%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue 00-45.01%658.5K-39.80%360K00200.00%298.5K74.06%1.2M598K0
Operating revenue --0--0-45.01%658.5K-39.80%360K--0--0200.00%298.5K74.06%1.2M--598K--0
Cost of revenue 00-44.78%518K-33.93%296K00217.14%222K77.46%938K448K0
Gross profit 00-45.86%140.5K-57.33%64K00159.32%76.5K62.79%259.5K150K0
Operating expense -20.06%3.19M-0.04%4M101.31%16.01M-0.12%4M34.11%4.01M357.61%4M4,530.64%4.01M2,643.70%7.95M5,050.84%4M4,080.34%2.99M
Selling and administrative expenses -10.84%1.32M-0.10%1.48M122.28%5.93M-0.32%1.48M71.91%1.49M537.51%1.48M1,617.04%1.49M820.39%2.67M1,807.93%1.48M1,112.18%867.21K
Research and development costs -25.47%1.88M0.00%2.52M90.72%10.08M0.00%2.52M18.67%2.52M292.69%2.52M--2.52M--5.29M--2.52M--2.12M
Operating profit 20.06%-3.19M-1.91%-4M-106.27%-15.87M-2.11%-3.93M-34.11%-4.01M-403.76%-4M-6,793.35%-3.93M-5,797.13%-7.69M-4,857.80%-3.85M-4,080.34%-2.99M
Net non-operating interest income expense -273.93%-789-277.03%-78859.86%-1.71K-289.60%-787-180.34%-49984.56%-21191.65%-20916.37%-4.25K90.63%-20288.58%-178
Non-operating interest expense 273.93%789277.03%788-59.86%1.71K289.60%787180.34%499-84.56%211-91.65%209-16.37%4.25K-90.63%202-88.58%178
Other net income (expense)
Income before tax 20.05%-3.2M-1.92%-4M-106.18%-15.87M-2.12%-3.93M-34.12%-4.01M-402.92%-4M-6,503.69%-3.93M-5,579.17%-7.7M-4,724.28%-3.85M-3,991.48%-2.99M
Income tax 0000000000
Net income 20.05%-3.2M-1.92%-4M-106.18%-15.87M-2.12%-3.93M-34.12%-4.01M-402.92%-4M-6,503.69%-3.93M-6,453.96%-7.7M-6,137.25%-3.85M-3,991.48%-2.99M
Net income continuous Operations 20.05%-3.2M-1.92%-4M-106.18%-15.87M-2.12%-3.93M-34.12%-4.01M-402.92%-4M-6,503.69%-3.93M-6,453.96%-7.7M-6,137.25%-3.85M-3,991.48%-2.99M
Minority interest income
Net income attributable to the parent company 20.05%-3.2M-1.92%-4M-106.18%-15.87M-2.12%-3.93M-34.12%-4.01M-402.92%-4M-6,503.69%-3.93M-6,453.96%-7.7M-6,137.25%-3.85M-3,991.48%-2.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.05%-3.2M-1.92%-4M-106.18%-15.87M-2.12%-3.93M-34.12%-4.01M-402.92%-4M-6,503.69%-3.93M-6,453.96%-7.7M-6,137.25%-3.85M-3,991.48%-2.99M
Basic earnings per share 28.57%-0.050.00%-0.07-85.71%-0.2614.29%-0.06-40.00%-0.07-250.00%-0.07-5,517.98%-0.07-5,593.37%-0.14-5,313.77%-0.07-3,165.84%-0.05
Diluted earnings per share 28.57%-0.050.00%-0.07-85.71%-0.2614.29%-0.06-40.00%-0.07-250.00%-0.07-5,517.98%-0.07-5,593.37%-0.14-5,313.77%-0.07-3,165.84%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg